Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Correction

Correction to: A systematic comparison of copy number alterations in four types of female cancer

Authors: Fatemeh Kaveh, Lars O. Baumbusch, Daniel Nebdal, Anne-Lise Børresen-Dale, Ole Christian Lingjærde, Hege Edvardsen, Vessela N. Kristensen, Hiroko K. Solvang

Published in: BMC Cancer | Issue 1/2018

Login to get access

Excerpt

After publication of the original article [1] the authors found that the article contained an incorrect version of Fig. 4. This does not affect the results and conclusions of the article. …
Metadata
Title
Correction to: A systematic comparison of copy number alterations in four types of female cancer
Authors
Fatemeh Kaveh
Lars O. Baumbusch
Daniel Nebdal
Anne-Lise Børresen-Dale
Ole Christian Lingjærde
Hege Edvardsen
Vessela N. Kristensen
Hiroko K. Solvang
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-017-3766-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine